Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年3月26日
	新闻
	New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR ... BioSpace --(BUSINESS WIRE)--New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's ... 标记为不相关
	MARIPOSA Confirms OS Benefit for Amivantamab/Lazertinib in EGFR+ NSCLC Targeted Oncology Peers & Perspectives in Oncology: What are the NCCN recommendations for frontline testing in patients with non–small cell lung cancer (NSCLC)?. VOKES: ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈